HBV in pregnancy: time to consider tenofovir alafenamide (TAF)
- PMID: 35793040
- DOI: 10.1007/s12072-022-10382-z
HBV in pregnancy: time to consider tenofovir alafenamide (TAF)
Comment on
-
Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy.Hepatol Int. 2022 Apr;16(2):211-253. doi: 10.1007/s12072-021-10285-5. Epub 2022 Feb 3. Hepatol Int. 2022. PMID: 35113359 Review.
References
-
- Kumar M, Abbas Z, Azami M, Belopolskaya M, Dokmeci AK, Ghazinyan H, et al. Asian pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy. Hep Intl. 2022;16(2):211–253 - DOI
-
- Zeng QL, Yu ZJ, Ji F, Li GM, Zhang GF, Xu JH, et al. Tenofovir alafenamide to prevent perinatal hepatitis B transmission: a multicenter, prospective. Observational Study Clin Infect Dis. 2021;73(9):e3324–e3332 - DOI
-
- Zeng QL, Zhang HX, Zhang JY, Huang S, Li WZ, Li GM, et al. Tenofovir alafenamide for pregnant chinese women with active chronic hepatitis B: a multicenter prospective study. Clin Gastroenterol Hepatol. 2021. https://doi.org/10.1016/j.cgh.2021.12.012 - DOI - PubMed
-
- Ding Y, Cao L, Zhu L, Huang Y, Lin C, Wang Y, et al. Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study. Aliment Pharmacol Ther. 2020;52(8):1377–1386 - PubMed
-
- Li B, Liu Z, Liu X, Liu D, Duan M, Gu Y, et al. Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load. Hepatol Int. 2021;15(5):1103–1108 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
